Taiho Pharmaceutical Co., Ltd.
Clinical trials sponsored by Taiho Pharmaceutical Co., Ltd., explained in plain language.
-
New drug targets rare gene fault in advanced cancers
Disease control Recruiting nowThis study tests an experimental drug (TAS0953/HM06) in people with advanced solid tumors that have a specific RET gene abnormality. The goal is to find the safest dose and see if the drug can shrink tumors. About 244 adults with RET-altered non-small cell lung cancer or other so…
Phase: PHASE1, PHASE2 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Could a pill replace shots for this bone marrow disease?
Disease control Recruiting nowThis early-phase study tests an oral combination of two drugs (ASTX030) for people with myelodysplastic syndrome (MDS), a bone marrow disorder. The goal is to find a dose that works as well as the standard injected treatment but in a more convenient pill form. About 40 adults wit…
Phase: PHASE1 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC